Amphastar Pharmaceuticals (AMPH) Intangibles (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Intangibles of $29.2 million for Q1 2026, little changed year-over-year from $29.2 million in Q1 2025, and little changed quarter-over-quarter from $29.2 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Intangibles (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Intangibles history runs 14 years deep, the most recent figure standing at $29.2 million for Q1 2026.
- In Q1 2026, Intangibles changed 0.0% year-over-year to $29.2 million; the TTM figure through Mar 2026 stood at $29.2 million (changed 0.0% YoY), while the FY2025 annual figure was $29.2 million, changed 0.0% from the prior year.
- Intangibles for Q1 2026 stood at $29.2 million, roughly flat from $29.2 million in the prior quarter.
- The five-year high for Intangibles was $29.2 million in Q2 2022, with the low at $29.2 million in Q1 2022.
- The 5-year median for Intangibles is $29.2 million (2022), against an average of $29.2 million.
- The sharpest annual moves came in 2022 and 2023: Intangibles decreased 0.09% in 2022, then advanced 0.09% in 2023.
- Amphastar Pharmaceuticals' Intangibles stood at $29.2 million in 2022, then changed by 0.0% to $29.2 million in 2023, then changed by 0.0% to $29.2 million in 2024, then changed by 0.0% to $29.2 million in 2025, then changed by 0.0% to $29.2 million in 2026.
- Business Quant data shows AMPH's Intangibles at $29.2 million in Q1 2026, $29.2 million in Q4 2025, and $29.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 1.12 Bn |
| 10 | Amphastar Pharmaceuticals | 942.71 Mn | 652.59 Mn | 93.47 Mn | 29.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.23 Mn |
| Mar 31, 2026 | 29.23 Mn |
| Dec 31, 2025 | 29.23 Mn |
| Sep 30, 2025 | 29.23 Mn |
| Jun 30, 2025 | 29.23 Mn |
| Mar 31, 2025 | 29.23 Mn |
| Dec 31, 2024 | 29.23 Mn |
| Sep 30, 2024 | 29.23 Mn |
| Jun 30, 2024 | 29.23 Mn |
| Mar 31, 2024 | 29.23 Mn |
| Dec 31, 2023 | 29.23 Mn |
| Sep 30, 2023 | 29.20 Mn |
| Jun 30, 2023 | 29.23 Mn |
| Mar 31, 2023 | 29.23 Mn |
| Dec 31, 2022 | 29.23 Mn |
| Sep 30, 2022 | 29.23 Mn |
| Jun 30, 2022 | 29.23 Mn |
| Mar 31, 2022 | 29.20 Mn |
| Dec 31, 2021 | 29.23 Mn |
| Sep 30, 2021 | 29.23 Mn |